SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-22-008950
Filing Date
2022-04-12
Accepted
2022-04-12 09:04:39
Documents
12
Period of Report
2022-02-28

Document Format Files

Seq Description Document Type Size
1 6-K a6-kxform6xkx2022q11.htm 6-K 13522
2 EX-99.1 organigramholdingsinc-mdae.htm EX-99.1 861554
3 EX-99.2 organigramholdingsinc-fsex.htm EX-99.2 990415
4 EX-99.3 a6-kxceocertificationex993.htm EX-99.3 17168
5 EX-99.4 a6-kxcfocertificationex994.htm EX-99.4 16717
6 EX-99.5 organigramholdingsinc-prex.htm EX-99.5 184189
7 a2022_q2xfinancialsxcovera.jpg GRAPHIC 2460477
8 a2022_q2xmdaxcover.jpg GRAPHIC 1944159
9 assets_inventory.jpg GRAPHIC 1045505
10 backcover.jpg GRAPHIC 1335185
11 backcoverb.jpg GRAPHIC 1335185
12 blueleafsa.gif GRAPHIC 559128
  Complete submission text file 0001628280-22-008950.txt   14014397
Mailing Address 35A ENGLISH DR. MONCTON A3 E1E 3X3
Business Address 35A ENGLISH DR. MONCTON A3 E1E 3X3 506-384-1571
ORGANIGRAM HOLDINGS INC. (Filer) CIK: 0001620737 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0831
Type: 6-K | Act: 34 | File No.: 001-38885 | Film No.: 22821203
SIC: 2834 Pharmaceutical Preparations